LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Mersana Therapeutics (NASDAQ: MRSN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ MRSN Mersana Therapeutics
Huber Martin H. Jr. / director, officer: President, CEO
09/12/2025
Sell
$7.31
2,012
$15K
9,572